These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38943321)

  • 1. PRPF40A induces inclusion of exons in GC-rich regions important for human myeloid cell differentiation.
    Tan CW; Sim DY; Zhen Y; Tian H; Koh J; Roca X
    Nucleic Acids Res; 2024 Aug; 52(15):8800-8814. PubMed ID: 38943321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SRSF2 directly inhibits intron splicing to suppresses cassette exon inclusion.
    Moon H; Cho S; Loh TJ; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zhou J; Cho S; Kim DE; Ye MB; Zheng X; Shen H
    BMB Rep; 2017 Aug; 50(8):423-428. PubMed ID: 28712387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between coding and exonic splicing regulatory sequences.
    Fontrodona N; Aubé F; Claude JB; Polvèche H; Lemaire S; Tranchevent LC; Modolo L; Mortreux F; Bourgeois CF; Auboeuf D
    Genome Res; 2019 May; 29(5):711-722. PubMed ID: 30962178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of RNA-binding protein SRSF2-dependent alternative splicing signature in malignant proliferation of colorectal carcinoma.
    Liu W; Li D; Lu T; Zhang H; Chen Z; Ruan Q; Zheng Z; Chen L; Guo J
    J Biol Chem; 2023 Feb; 299(2):102876. PubMed ID: 36623729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human PRPF40B regulates hundreds of alternative splicing targets and represses a hypoxia expression signature.
    Lorenzini PA; Chew RSE; Tan CW; Yong JY; Zhang F; Zheng J; Roca X
    RNA; 2019 Aug; 25(8):905-920. PubMed ID: 31088860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Cryptic 3' Splice-Sites by SRSF2 Contributes to Cassette Exon Skipping.
    Moon H; Jang HN; Liu Y; Choi N; Oh J; Ha J; Zheng X; Shen H
    Cells; 2019 Jul; 8(7):. PubMed ID: 31295920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SON and SRRM2 are essential for nuclear speckle formation.
    Ilik İA; Malszycki M; Lübke AK; Schade C; Meierhofer D; Aktaş T
    Elife; 2020 Oct; 9():. PubMed ID: 33095160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons and is itself regulated by lysine mono-methylation.
    Carlson SM; Soulette CM; Yang Z; Elias JE; Brooks AN; Gozani O
    J Biol Chem; 2017 Aug; 292(32):13381-13390. PubMed ID: 28655759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splicing Enhancers at Intron-Exon Borders Participate in Acceptor Splice Sites Recognition.
    Kováčová T; Souček P; Hujová P; Freiberger T; Grodecká L
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRRM2 organizes splicing condensates to regulate alternative splicing.
    Xu S; Lai SK; Sim DY; Ang WSL; Li HY; Roca X
    Nucleic Acids Res; 2022 Aug; 50(15):8599-8614. PubMed ID: 35929045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Liu S; Lin C; Lin X; Lin P; He R; Pan X; Lin Y; Ye J; Zhu G
    Cancer Res; 2024 Oct; 84(19):3207-3222. PubMed ID: 39024555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3.
    Wei Z; Wang Y; Ma W; Xing W; Lu P; Shang Z; Li F; Li H; Wang Y
    RNA Biol; 2023 Jan; 20(1):359-367. PubMed ID: 37335045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting serine- and arginine-rich splicing factors to rectify aberrant alternative splicing.
    Li D; Yu W; Lai M
    Drug Discov Today; 2023 Sep; 28(9):103691. PubMed ID: 37385370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRSF9 Regulates Cassette Exon Splicing of Caspase-2 by Interacting with Its Downstream Exon.
    Ha J; Jang H; Choi N; Oh J; Min C; Pradella D; Jung DW; Williams DR; Park D; Ghigna C; Zheng X; Shen H
    Cells; 2021 Mar; 10(3):. PubMed ID: 33808656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics detection of modulators controlling splicing factor-dependent intron retention in the human brain.
    Chen SX; Simpson E; Reiter JL; Liu Y
    Hum Mutat; 2022 Nov; 43(11):1629-1641. PubMed ID: 35391504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development.
    Grellscheid S; Dalgliesh C; Storbeck M; Best A; Liu Y; Jakubik M; Mende Y; Ehrmann I; Curk T; Rossbach K; Bourgeois CF; Stévenin J; Grellscheid D; Jackson MS; Wirth B; Elliott DJ
    PLoS Genet; 2011 Dec; 7(12):e1002390. PubMed ID: 22194695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene architecture directs splicing outcome in separate nuclear spatial regions.
    Tammer L; Hameiri O; Keydar I; Roy VR; Ashkenazy-Titelman A; Custódio N; Sason I; Shayevitch R; Rodríguez-Vaello V; Rino J; Lev Maor G; Leader Y; Khair D; Aiden EL; Elkon R; Irimia M; Sharan R; Shav-Tal Y; Carmo-Fonseca M; Ast G
    Mol Cell; 2022 Mar; 82(5):1021-1034.e8. PubMed ID: 35182478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10 inclusion.
    Yin X; Jin N; Gu J; Shi J; Zhou J; Gong CX; Iqbal K; Grundke-Iqbal I; Liu F
    J Biol Chem; 2012 Aug; 287(36):30497-506. PubMed ID: 22767602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation.
    Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM
    RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of programmable splicing factors using RNA-binding proteins that activate exon inclusion.
    Nat Biotechnol; 2024 Sep; 42(9):1364-1365. PubMed ID: 38168983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.